These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 402373)

  • 21. [Final stages of the preliminary metabolism of 2,4,6-trinitrotoluene in Pseudomonas fluorescens].
    Selizanovskaia SIu; Akhmetova DZ; Naumova RP
    Mikrobiologiia; 1986; 55(6):1040-1. PubMed ID: 3102912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of salinity and temperature on fatty acid composition of Pseudomonas fluorescens GNP-OHP-3 membrane].
    Pucci GN; Härtig C; Pucci OH
    Rev Argent Microbiol; 2004; 36(1):6-15. PubMed ID: 15174743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of growth conditions on Pseudomonas fluorescens strains: a link between metabolite production and the PLFA profile.
    Fouchard S; Abdellaoui-Maâne Z; Boulanger A; Llopiz P; Neunlist S
    FEMS Microbiol Lett; 2005 Oct; 251(2):211-8. PubMed ID: 16143465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetranactin, a new miticidal antibiotic. VI. Determination of dinactin, trinactin and tetranactin in their mixtures by NMR spectroscopy.
    Haneda M; Nawata Y; Hayashi T; Ando K
    J Antibiot (Tokyo); 1974 Jul; 27(7):555-7. PubMed ID: 4457535
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel fatty acid from laspartomycin.
    Naganawa H; Takita T; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1970 Aug; 23(8):423-4. PubMed ID: 5453320
    [No Abstract]   [Full Text] [Related]  

  • 26. Revised structure for the phenazine antibiotic from Pseudomonas fluorescens 2-79 (NRRL B-15132).
    Brisbane PG; Janik LJ; Tate ME; Warren RF
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1967-71. PubMed ID: 3125789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimycoplasmal activities of the pseudomonic acids and structure-activity relationships of monic acid A derivatives.
    Banks RM; Donald AC; Hannan PC; O'Hanlon PJ; Rogers NH
    J Antibiot (Tokyo); 1988 May; 41(5):609-13. PubMed ID: 3133344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies concerning the antibiotic actinonin. Part I. The constitution of actinonin. A natural hydroxamic acid with antibiotic activity.
    Gordon JJ; Devlin JP; East AJ; Ollis WD; Wright DE; Ninet L
    J Chem Soc Perkin 1; 1975; (9):819-25. PubMed ID: 1170208
    [No Abstract]   [Full Text] [Related]  

  • 29. Spectroscopic characterization and identification of Pseudomonas fluorescens mediated metabolic products of Acid Yellow-9.
    Pandey BV; Upadhyay RS
    Microbiol Res; 2006; 161(4):311-5. PubMed ID: 16412621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid constituents of the antifungal antibiotic stendomycin.
    Bodanszky M; Muramatsu I; Bodanszky A
    J Antibiot (Tokyo); 1967 Nov; 20(6):384-5. PubMed ID: 5631372
    [No Abstract]   [Full Text] [Related]  

  • 31. Karalicin, a new biologically active compound from Pseudomonas fluorescens/putida. I. Production, isolation, physico-chemical properties and structure elucidation.
    Lampis G; Deidda D; Maullu C; Petruzzelli S; Pompei R; Monache FD; Satta G
    J Antibiot (Tokyo); 1996 Mar; 49(3):260-2. PubMed ID: 8626241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-1008, a new antibiotic of bacterial origin containing a spermidine moiety. Production, isolation, characterization and biological properties.
    Kido Y; Harada T; Yoshida T; Umemoto J; Motoki Y
    J Antibiot (Tokyo); 1980 Aug; 33(8):791-5. PubMed ID: 6776084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The revised structure of viscosin, a peptide antibiotic.
    Hiramoto M; Okada K; Nagai S
    Tetrahedron Lett; 1970 Mar; (13):1087-90. PubMed ID: 5439239
    [No Abstract]   [Full Text] [Related]  

  • 34. EM49, a new peptide antibiotic IV. The structure of EM49.
    Parker WL; Rathnum ML
    J Antibiot (Tokyo); 1975 May; 28(5):379-89. PubMed ID: 170240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STRUCTURE DETERMINATION OF FATTY ACIDS FROM THE ANTIBIOTIC ASPARTOCIN.
    HAUSMANN WK; STRUCK AH; MARTIN JH; BARRITT RH; BOHONOS N
    Antimicrob Agents Chemother (Bethesda); 1963; 161():352-9. PubMed ID: 14274924
    [No Abstract]   [Full Text] [Related]  

  • 36. Structure of carzinophilin. IV. Structure elucidation by nuclear magnetic resonance spectroscopy. (2).
    Onda M; Konda Y; Hatano A; Hata T; Omura S
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2995-3002. PubMed ID: 6518583
    [No Abstract]   [Full Text] [Related]  

  • 37. The structure of pactamycin.
    Wiley PF; Jahnke HK; MacKellar F; Kelly RB; Argoudelis AD
    J Org Chem; 1970 May; 35(5):1420-5. PubMed ID: 5440331
    [No Abstract]   [Full Text] [Related]  

  • 38. The structure of feldamycin.
    Argoudelis AD; Mizsak SA; Baczynskyj L; Wnuk RJ
    J Antibiot (Tokyo); 1976 Oct; 29(10):1117-9. PubMed ID: 994330
    [No Abstract]   [Full Text] [Related]  

  • 39. Structure confirmation of triostin a by 1H and 13C magnetic resonance.
    Otsuka H; Shoji J; Kawano K; Kyogoku Y
    J Antibiot (Tokyo); 1976 Jan; 29(1):107-10. PubMed ID: 931789
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective mono-Claisen rearrangement of carbohydrate glycals. A chemical consequence of the vinylogous anomeric effect.
    Curran DP; Suh YG
    Carbohydr Res; 1987 Dec; 171():161-91. PubMed ID: 3127051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.